NASDAQ : CABR
Caring Brands, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 1.07 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 11.09M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Caring Brands, Inc. (CABR) reported revenue of 1.16K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 1.16K | 4.21K | 465.00 | 20.42K | 69.97K |
| Cost of Revenue | 473.00 | 1.87K | 2.07K | 118.87K | 188.99K |
| Gross Profit | 686.00 | 2.34K | -1.61K | -98.45K | -119.01K |
| Selling, General & Admin | 4.40M | 3.09M | 1.38M | 52.94K | 131.67K |
| Operating Expenses | 4.55M | 3.39M | 1.53M | 52.94K | 131.67K |
| Operating Income | -4.55M | -3.39M | -1.53M | -151.39K | -250.68K |
| Interest Expense | -305.77K | -19.17K | -67.00 | ||
| Interest & Investment Income | 10.03K | ||||
| Other Non Operating Income (Expenses) | 1.06K | 1.00K | |||
| EBT Excluding Unusual Items | -4.85M | -3.40M | -1.52M | -151.39K | -250.68K |
| Gain (Loss) on Sale of Investments | -500.00K | -500.00K | |||
| Gain (Loss) on Sale of Assets | 23.31K | ||||
| Asset Writedown | -2.55M | -2.55M | |||
| Other Unusual Items | 175.00K | 175.00K | |||
| Pretax Income | -7.73M | -6.28M | -1.52M | -128.09K | -250.68K |
| Net Income | -7.73M | -6.28M | -1.52M | -128.09K | -250.68K |
| Preferred Dividends & Other Adjustments | 2.15M | -654.64K | |||
| Net Income to Common | -9.88M | -6.28M | -862.79K | -128.09K | -250.68K |
| Shares Outstanding (Basic) | 12.78M | 13.57M | 13.09M | ||
| Shares Outstanding (Diluted) | 12.78M | 13.57M | 13.09M | ||
| EPS (Basic) | -0.77 | -0.46 | -0.07 | ||
| EPS (Diluted) | -0.77 | -0.46 | -0.07 | ||
| Free Cash Flow | -2.26M | -1.69M | -823.99K | -58.63K | -87.97K |
| Free Cash Flow Per Share | -0.18 | -0.12 | -0.06 | ||
| Gross Margin | 59.19% | 55.56% | -170.09% | ||
| Operating Margin | -392,263.59% | -80,309.01% | -328,471.83% | -741.36% | -358.26% |
| Profit Margin | -852,192.24% | -148,948.78% | -185,546.45% | -627.23% | -358.26% |
| Free Cash Flow Margin | -194,566.01% | -40,148.47% | -177,202.37% | -287.12% | -125.72% |
| EBITDA | -4.25M | -3.09M | -1.38M | -149.19K | -241.88K |
| D&A For EBITDA | 300.00K | 300.00K | 150.00K | 2.20K | 8.80K |
| EBIT | -4.55M | -3.39M | -1.53M | -151.39K | -250.68K |
| Advertising Expenses | 4.43K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.82M | 2.19M | 469.00K | 18.16K | 22.30K |
| Cash & Short-Term Investments | 1.82M | 2.19M | 469.00K | 18.16K | 22.30K |
| Receivables | 354.00 | 372.00 | |||
| Inventory | 12.81K | 12.81K | 13.69K | 81.24K | |
| Prepaid Expenses | 76.45K | 124.78K | 44.79K | 4.40K | |
| Total Current Assets | 1.91M | 2.33M | 527.48K | 22.91K | 103.92K |
| Property, Plant & Equipment | 17.99K | ||||
| Other Intangible Assets | 2.85M | ||||
| Other Long-Term Assets | 500.00K | ||||
| Total Assets | 1.91M | 2.33M | 3.88M | 22.91K | 121.91K |
| Accounts Payable | 293.81K | 170.35K | 169.43K | 20.66K | 1.96K |
| Accrued Expenses | 90.84K | 6.49K | 16.67K | 1.07K | |
| Other Current Liabilities | 6.08K | ||||
| Total Current Liabilities | 384.65K | 176.84K | 186.10K | 21.73K | 8.03K |
| Long-Term Debt | 58.65K | 266.95K | 251.56K | ||
| Total Liabilities | 384.65K | 235.49K | 186.10K | 288.69K | 259.60K |
| Common Stock | 267.87K | 97.77K | 13.11K | ||
| Additional Paid-In Capital | 6.96M | 9.14M | 4.54M | ||
| Retained Earnings | -9.79M | -7.14M | -862.79K | -265.77K | -137.69K |
| Comprehensive Income & Other | -800.00 | -800.00 | |||
| Shareholders' Equity | 1.52M | 2.09M | 3.69M | -265.77K | -137.69K |
| Total Liabilities & Equity | 1.91M | 2.33M | 3.88M | 22.91K | 121.91K |
| Total Debt | 58.65K | 266.95K | 251.56K | ||
| Net Cash (Debt) | 1.82M | 2.13M | 469.00K | -248.79K | -229.26K |
| Net Cash Per Share | 0.14 | 0.16 | 0.04 | ||
| Filing Date Shares Outstanding | 10.37M | 12.34M | 13.34M | ||
| Total Common Shares Outstanding | 9.09M | 14.76M | 13.11M | ||
| Working Capital | 1.52M | 2.15M | 341.38K | 1.18K | 95.88K |
| Book Value Per Share | -0.30 | 0.14 | 0.28 | ||
| Tangible Book Value | -2.71M | 2.09M | 841.38K | -265.77K | -137.69K |
| Tangible Book Value Per Share | -0.30 | 0.14 | 0.06 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -7.73M | -6.28M | -1.52M | -128.09K | -250.68K |
| Depreciation & Amortization | 150.00K | 300.00K | 150.00K | 2.20K | 8.80K |
| Other Amortization | 148.02K | 6.67K | |||
| Loss (Gain) From Sale of Assets | -23.31K | ||||
| Asset Writedown & Restructuring Costs | 2.55M | 2.55M | |||
| Loss (Gain) From Sale of Investments | 500.00K | 500.00K | |||
| Stock-Based Compensation | 1.81M | 1.24M | 400.00K | ||
| Provision & Write-off of Bad Debts | 2.27K | ||||
| Other Operating Activities | 175.00K | 175.00K | |||
| Change in Accounts Receivable | 354.00 | 18.00 | 3.91K | ||
| Change in Inventory | 240.00 | 882.00 | 81.24K | 167.54K | |
| Change in Accounts Payable | 21.42K | -95.10K | 140.88K | 18.71K | 910.00 |
| Change in Other Net Operating Assets | 120.70K | -90.17K | 2.21K | -9.41K | 6.08K |
| Operating Cash Flow | -2.26M | -1.69M | -823.99K | -58.63K | -61.17K |
| Capital Expenditures | -26.79K | ||||
| Sale of Property, Plant & Equipment | 39.10K | ||||
| Cash Acquisitions | 608.60K | ||||
| Investing Cash Flow | 608.60K | 39.10K | -26.79K | ||
| Short-Term Debt Issued | 120.00K | 666.23K | |||
| Long-Term Debt Issued | 170.00K | 15.39K | 100.57K | ||
| Total Debt Issued | 4.11M | 290.00K | 666.23K | 15.39K | 100.57K |
| Short-Term Debt Repaid | -120.00K | ||||
| Total Debt Repaid | -120.00K | -120.00K | |||
| Net Debt Issued (Repaid) | 3.99M | 170.00K | 666.23K | 15.39K | 100.57K |
| Issuance of Common Stock | 3.24M | 3.24M | |||
| Financing Cash Flow | 4.00M | 3.41M | 666.23K | 15.39K | 100.57K |
| Net Cash Flow | 1.75M | 1.72M | 450.84K | -4.14K | 12.60K |
| Free Cash Flow | -2.26M | -1.69M | -823.99K | -58.63K | -87.97K |
| Free Cash Flow Margin | -194,566.01% | -40,148.47% | -177,202.37% | -287.12% | -125.72% |
| Free Cash Flow Per Share | -0.18 | -0.12 | -0.06 | ||
| Levered Free Cash Flow | -752.38K | -670.67K | -294.02K | -1.86K | |
| Unlevered Free Cash Flow | -709.29K | -665.36K | -293.98K | -1.86K | |
| Change in Working Capital | 142.36K | -184.38K | 143.44K | 90.56K | 178.44K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 10.78M | 12.64M | |||
| Enterprise Value | 8.96M | 12.76M | |||
| Last Close Price | 1.04 | 0.86 | |||
| PS Ratio | 9,303.67 | 2,999.13 | |||
| PB Ratio | 7.07 | 6.04 | |||
| P/TBV Ratio | 6.04 | ||||
| EV/Sales Ratio | 7,733.04 | 3,026.45 | |||
| Debt / Equity Ratio | 0.03 | -1.00 | -1.83 | ||
| Net Debt / Equity Ratio | -1.19 | -1.02 | -0.13 | -0.94 | -1.67 |
| Net Debt / EBITDA Ratio | 0.43 | 0.69 | 0.34 | -1.67 | -0.95 |
| Net Debt / FCF Ratio | 0.81 | 1.26 | 0.57 | -4.24 | -2.61 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.28 | |
| Inventory Turnover | 0.04 | 0.14 | |||
| Quick Ratio | 4.73 | 12.38 | 2.52 | 0.85 | 2.82 |
| Current Ratio | 4.96 | 13.16 | 2.83 | 1.05 | 12.94 |
| Return on Equity (ROE) | -333.74% | -217.14% | -88.59% | ||
| Return on Assets (ROA) | -108.32% | -68.20% | -48.95% | -130.67% | |
| Return on Capital Employed (ROCE) | -298.10% | -157.40% | -41.40% | -12,819.10% | -220.10% |
| Earnings Yield | -74.31% | -49.66% | |||
| FCF Yield | -20.91% | -13.39% | |||
| Buyback Yield / Dilution | 4.18% | -3.63% |